A Multi-Centre Randomised Trial Comparing Ultrasound Vs Mammography for Screening Breast Cancer in High-Risk Chinese Women.
S Shen,Y Zhou,Y Xu,B Zhang,X Duan,R Huang,B Li,Y Shi,Z Shao,H Liao,J Jiang,N Shen,J Zhang,C Yu,H Jiang,S Li,S Han,J Ma,Q Sun
DOI: https://doi.org/10.1038/bjc.2015.33
IF: 9.075
2015-01-01
British Journal of Cancer
Abstract:BACKGROUND:Chinese women tend to have small and dense breasts and ultrasound is a common method for breast cancer screening in China. However, its efficacy and cost comparing with mammography has not been evaluated in randomised trials.METHODS:At 14 breast centres across China during 2008-2010, 13 339 high-risk women aged 30-65 years were randomised to be screened by mammography alone, ultrasound alone, or by both methods at enrollment and 1-year follow-up.RESULTS:A total of 12 519 and 8692 women underwent the initial and second screenings, respectively. Among the 30 cancers (of which 15 were stage 0/I) detected, 5 (0.72/1000) were in the mammography group, 11 (1.51/1000) in the ultrasound group, and 14 (2.02/1000) in the combined group (P=0.12). In the combined group, ultrasound detected all the 14 cancers, whereas mammography detected 8, making ultrasound more sensitive (100 vs 57.1%, P=0.04) with a better diagnostic accuracy (0.999 vs 0.766, P=0.01). There was no difference between mammography and ultrasound in specificity (100 vs 99.9%, P=0.51) and positive predictive value (72.7 vs 70.0%; P=0.87). To detect one cancer, the costs of ultrasound, mammography, and combined modality were $7876, $45 253, and $21 599, respectively.CONCLUSIONS:Ultrasound is superior to mammography for breast cancer screening in high-risk Chinese women.